Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Cedilla Therapeutics
Cedilla develops therapeutic technologies to treat diseases caused by protein dysregulation.
Sector
Subsector
Keywords
Location
total rounds
total raised
Tegmine Therapeutics
Tegmine Therapeutics develops antibody-based therapeutics targeting proteins and their disease-related glycan modifications.
Sector
Subsector
Keywords
Location
total rounds
Ensemble Therapeutics
Ensemble discovers and develops small molecule therapies for cancer and other serious diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
JURA Bio
Jura Bio develops cell-based therapies for autoimmune disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds8
Number of Funding Rounds
Money Raised
Their latest funding was raised on 14.09.2021. Their latest investor The Duke of Bedford. Their latest round Venture - Series Unknown
Fidelity Management and Research Company
Fidelity Management and Research Company is a private investment manager that aims to make financial expertise accessible to everyone.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
The Duke of Bedford
The Duke of Bedford
count Of Investments
Good Growth Capital
Good Growth Capital invests in science and deep-tech start-ups.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Celgene
Celgene develops and sells innovative therapies for cancer and immune-inflammatory diseases.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders2
Kathleen McCarthy
Kathleen McCarthy is a Senior Managing Director and Global Chief Operating Officer of the Blackstone Real Estate group. She is based in New York. Kathleen McCarthy oversees Real Estate Investor Relations and Business Development, Human Resources, Legal & Compliance and Finance. Previously she was responsible for marketing Blackstone's real estate private investment funds. Before joining Blackstone in 2010, Kathleen McCarthy worked at Goldman Sachs, where she was a Vice President focused on investments for the Real Estate Principal Investment Area. Kathleen McCarthy began her career at Goldman Sachs as an Analyst in the Mergers & Strategic Advisory Group within the Investment Banking Division. Kathleen McCarthy received a BA with Distinction from Yale University.
current job
Kathleen McCarthy
Bill Haney
Co-founder & CEO of Dragonfly Therapeutics & Skyhawk Therapeutics.
current job
organization founded
Bill Haney
Employee Profiles14
Irene Berner
Senior director, project and alliance management
Activity
Recent News5
The graph reveals the ratio (%) of positive news articles in a chosen time range